STAT1 min gelesen
Opinion: Why Brain Decoding Is Not Mind Reading — And Why That Matters
It is never too early to think about the ethical issues that can arise from any new technology.
STAT1 min gelesen
STAT+: ASCO Showcased The Payoff For New Cancer Medicines: Longer Lives
As new cancer drugs arrive, regulators and doctors still struggle with when to use drugs based on earlier data and when to wait for survival data. #ASCO23
STAT2 min gelesen
STAT+: Pharmalittle: U.K. Launches Pilot To Expand Access To Weight Loss Drugs; European Union Approves RSV Vaccine
The U.K. will launch a $50 million pilot program to explore how new weight-loss drugs can be given to more people outside hospitals.
STAT1 min gelesen
Opinion: How The Conversation About Moral Injury In Health Care Is Changing
In the new book “If I Betray These Words,” I tell the story, with Simon Talbot, of Rita Gallardo (a pseudonym): Deployed in the desert Middle East, confined to a military base ringed by Hesco barriers and razor wire, Dr. Rita Gallardo’s only escape f
STAT2 min gelesenCrime & Violence
STAT+: Pharmalittle: Merck Sues U.S. To Halt Medicare Drug-price Negotiation; FDA Oncology Head Wants Advisory Panels To Keep Voting On New Drugs
Merck sued the U.S. government, seeking an injunction to block the drug-price negotiation program contained in the Inflation Reduction Act.
STAT1 min gelesen
STAT+: FDA Oncology Head Wants Advisory Panels To Keep Voting On New Drugs
“I think we need to vote," said the FDA's oncology chief, Richard Pazdur. "We have to make a binary decision at FDA whether to or not to approve. If we…
STAT2 min gelesen
STAT+: Pharmalittle: AstraZeneca Lung Cancer Drug Halves Death Risk; 400 Grail Patients Incorrectly Told They May Have Cancer
Giving an AstraZeneca drug called Tagrisso to patients with non-small cell lung cancer who have had their tumors removed reduced the risk of death by 51%.
STAT2 min gelesen
STAT+: Pharmalittle: Medicare Holds Firm On Alzheimer’s Drug Coverage Policy; Pfizer Says Antibiotic Combo Can Treat Some Superbugs
Despite pressure from Congress and advocates, Medicare is not changing its coverage plan for new Alzheimer's drugs anytime soon.
STAT1 min gelesen
STAT+: Pharmalittle: Coherus Undercuts AbbVie With Discounted Humira; FDA Approves Second RSV Vaccine
Coherus BioSciences plans to sell a Humira biosimilar at a steep discount and will work with Mark Cuban’s generic drug company to sell it to consumers.
STAT1 min gelesenCrime & Violence
STAT+: Pharmalittle: Appeals Court Rules Purdue Can Shield Sacklers From Lawsuits; Chemo Shortage Blamed On Drugmakers’ Lack Of Investment
A U.S. appeals court ruled that Purdue Pharma can shield its owners from lawsuits over the company's role in the opioid crisis as part of a bankruptcy settlement.
STAT2 min gelesen
STAT+: Pharmalittle: Pfizer Touts Study Data For Hemophilia Drug; Former Novartis Execs Cleared Of Bribery In Greece
A report by nonpartisan congressional researchers suggests there are at least some parts of the new drug pricing law that drugmakers cannot challenge.
STAT2 min gelesen
STAT+: Pharmalittle: EMA Urges Revoking Authorization For Novartis Sickle Cell Drug; U.K. Tries To Placate Pharma Execs
The European Medicines Agency recommended revoking marketing authorization for a Novartis sickle cell disease drug called Adakveo.
STAT1 min gelesen
Opinion: STAT+: An Overlooked Way To Make Participants In Clinical Trials Look More Like America
Underrepresentation of population subgroups in clinical research is bad for the health of Americans.
STAT3 min gelesen
STAT+: With Fat Joe Concerts And Super Bowl Ads, A Cadre Of Billionaires Is Mounting An Unorthodox Campaign Against Hospitals
A small club of billionaires is using unorthodox tactics — and piles of cash and connections — to campaign to rein in hospital prices.
STAT2 min gelesen
STAT+: Pharmalittle: FDA Approvals Will Stop If U.S. Defaults On Its Debts; DEA Failed To Punish Wholesaler Blamed In Opioid Crisis
The FDA delayed its decision on a gene therapy for Duchenne muscular dystrophy and is leaning toward clearing it for only a subset of younger kids.
STAT2 min gelesen
STAT+: Pharmalittle: Biden Administration Proposes Yearly Audit For Costliest Medicaid Drugs; Few At High Risk Of HIV Take Prevention Pills
The administration is planning a yearly audit to verify prices drugmakers charge on a handful of the costliest prescriptions covered by Medicaid.
STAT2 min gelesen
STAT+: Pharmalittle: Pfizer And Novo Disclose Upbeat Data On Oral Weight Loss Drugs; PBM Trade Group Blasts House Committee Over Hearing
An oral version of semaglutide, the drug marketed as Ozempic and Wegovy, led to dramatic weight loss in a trial enrolling people with obesity.
STAT2 min gelesen
STAT+: Pharmalittle: Many Employer Health Plans Won’t Pay For Obesity Drugs; FDA Panel Rejects Intercept NASH Drug
A FDA advisory panel voted against approving an investigational treatment from Intercept Pharmaceuticals for treating NASH.
STAT2 min gelesen
STAT+: Pharmalittle: AstraZeneca Plans To ‘Love’ China’s Communist Party; U.S. Supreme Court Rules Against Amgen In Patent Case
The U.S. Supreme Court upheld a ruling that Amgen failed to disclose sufficient information about patent claims for its cholesterol drug Repatha.
STAT2 min gelesenAmerican Government
STAT+: Pharmalittle: Appellate Judges Appear Skeptical Of FDA Decisions On Abortion Pill; FTC Widens Probe Into PBMs
A federal appeals court panel heard arguments in a case that could determine the future of a commonly used abortion pill.
STAT2 min gelesenAmerican Government
STAT+: Pharmalittle: FTC Suit Over Amgen Spotlights ‘Bundling’ Deals With Insurers; FDA Staff Says Pfizer RSV Vaccine Is Effective
The FTC's suit to block Amgen from acquiring Horizon Therapeutics cast a spotlight on a practice known as bundling.
STAT1 min gelesen
STAT+: Biden Drug Czar To Summon Naloxone Makers To White House To Discuss Pricing
The White House drug czar is summoning naloxone makers for a meeting to address the price of naloxone, a medication used to reverse opioid overdoses.
STAT2 min gelesenAmerican Government
STAT+: Pharmalittle: FTC May Sue To Block Amgen Deal For Horizon; Supreme Court Declines Teva Appeal On Skinny Labeling
The FTC is expected to file a lawsuit to block Amgen from acquiring Horizon Therapeutics, arguing the $27.8 billion deal would hamper innovation.
STAT1 min gelesen
STAT+: Ketamine Clinics’ Bust Serves As Warning Of Business Challenge Facing Psychedelic Therapy
The clinic closures signaled an abrupt halt to a scramble to dominate the North American market for administering ketamine.
STAT2 min gelesen
STAT+: Pharmalittle: FDA OKs New Kind Of Drug To Treat Hot Flashes; Alzheimer’s Drug Could Cost Medicare Up To $5 Billion A Year
The FDA approved a new kind of drug to treat hot flashes, which could offer relief to women who do not want to take hormone therapy.
STAT2 min gelesen
STAT+: Pharmalittle: U.S. Senate Committee Passes PBM Bills; Pfizer CEO Predicts Pharma Will Sue Over Medicare Price Negotiations
The U.S. Senate health committee passed a package of bills aimed at speeding generic drug competition and reining in pharmacy benefit managers.
STAT1 min gelesen
STAT+: Pharmalittle: FDA Panel Recommends First OTC Birth Control Pill; Senate Hearing On Insulin Costs Satisfies No One
An advisory panel of independent experts voted unanimously that the FDA should approve the first over-the-counter birth control pill.
STAT1 min gelesen
STAT+: Pharmalittle: Gilead Wins Lawsuit Against HHS Over HIV Pill Patents; Most Americans Say Abortion Pill Should Remain On The Market
Gilead Sciences prevailed in a closely watched battle with the U.S. government over the rights to groundbreaking HIV prevention pills.
STAT1 min gelesenChemistry
Opinion: The IRA’s Nonsensical Distinction Between Small- And Large-molecule Drugs
Thanks to advances in science, notably the completion of the Human Genome Project 20 years ago, we are able to treat diseases more effectively than ever before. Researchers have more sophisticated tools not only to identify new drug targets, but also
STAT1 min gelesen
STAT+: Pharmalittle: Big Pharma Maps Legal Strategy Against U.S. Drug Pricing Reform; U.S. Pharma Layoffs Continue To Climb
The number of layoffs in the U.S. pharmaceutical industry continued at a brisk rate last month as another 600 jobs were eliminated.
...oder etwas Neues entdecken